UniRDC™ is a proprietary discovery platform, which rationalizes and accelerates the discovery process of RDC drug candidates. UniRDC™ enables a short discovery timeline of 18 months or less from a target to an RDC development candidate with human biodistribution data, which has been repeatedly validated internally. 

UniRDC™ covers a range of modalities including small molecule, cyclic peptide, and nanobody. It is centered on a rich set of proprietary synthetic chemistry and protein engineering tool kits including linker technology and modification methods. Such tool kits have been proven to be essential to rapidly turn an affinity matured binder to a development candidate with therapeutically optimal biodistribution profile.